Cargando…

Association of Glycation Gap With Mortality and Vascular Complications in Diabetes

OBJECTIVE: The “glycation gap” (G-gap), an essentially unproven concept, is an empiric measure of disagreement between HbA(1c) and fructosamine, the two indirect estimates of glycemic control. Its association with demographic features and key clinical outcomes in individuals with diabetes is uncerta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nayak, Ananth U., Nevill, Alan M., Bassett, Paul, Singh, Baldev M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781552/ https://www.ncbi.nlm.nih.gov/pubmed/23835697 http://dx.doi.org/10.2337/dc12-1040

Ejemplares similares

Evidence for Consistency of the Glycation Gap in Diabetes
por: Nayak, Ananth U., et al.
Publicado: (2011)

Glycation Gap Is Associated With Macroproteinuria but Not With Other Complications in Patients With Type 2 Diabetes
por: Cosson, Emmanuel, et al.
Publicado: (2013)

Risk of COVID-19 hospital admission and COVID-19 mortality during the first COVID-19 wave with a special emphasis on ethnic minorities: an observational study of a single, deprived, multiethnic UK health economy
por: Singh, Baldev M, et al.
Publicado: (2021)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
por: Rhee, Sang Youl, et al.
Publicado: (2018)

Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)

Glycation and Age in Diabetes and Complications
por: Turk, Zdenka
Publicado: (2002)

Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics
por: Schalkwijk, Casper G., et al.
Publicado: (2010)

Receptor for advanced glycation end‐products‐mediated inflammation and diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2011)

Controlling the receptor for advanced glycation end‐products to conquer diabetic vascular complications
por: Yamamoto, Yasuhiko, et al.
Publicado: (2012)

Estimation of the Glycation Gap in Diabetic Patients With Stable Glycemic Control
por: Rodríguez-Segade, Santiago, et al.
Publicado: (2012)

Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
por: Guerin-Dubourg, Alexis, et al.
Publicado: (2017)

Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
por: Lee, Jeongmin, et al.
Publicado: (2022)

Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention
por: Brings, Sebastian, et al.
Publicado: (2017)

Thiamine pyrophosphate improved vascular complications of diabetes in rats with type 2 diabetes by reducing glycation, oxidative stress, and inflammation markers
por: Mahdavifard, Sina, et al.
Publicado: (2020)

Complications in the spine associated with type 2 diabetes: The role of advanced glycation end-products
por: Broz, Kaitlyn, et al.
Publicado: (2021)

Consistency of the Glycation Gap with the Hemoglobin Glycation Index Derived from a Continuous Glucose Monitoring System
por: Joung, Han Na, et al.
Publicado: (2020)

Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes
por: Maher, Pamela, et al.
Publicado: (2011)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
por: Mengstie, Misganaw Asmamaw, et al.
Publicado: (2022)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
por: van Steen, Sigrid C., et al.
Publicado: (2018)

Global trend of diabetes mortality attributed to vascular complications, 2000–2016
por: Ling, Wei, et al.
Publicado: (2020)

Glycated Hemoglobin and All-Cause Mortality in Korean Type 2 Diabetes
por: An, Mi Suk, et al.
Publicado: (2017)

Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
por: Yoon, Hye-jin, et al.
Publicado: (2015)

Glycated hemoglobin variability: A potential new risk marker for diabetes complications?
por: Jia, Weiping
Publicado: (2014)

Increased Expression of Tissue Factor and Receptor for Advanced Glycation End Products in Peripheral Blood Mononuclear Cells of Patients With Type 2 Diabetes Mellitus with Vascular Complications
por: Buchs, A. E., et al.
Publicado: (2004)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications
por: Kalaria, Tejaskumar R., et al.
Publicado: (2016)

Observational cross-sectional study of the association of poor broadband provision with demographic and health outcomes: the Wolverhampton Digital ENablement (WODEN) programme
por: Philp, Fraser, et al.
Publicado: (2022)

Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes
por: Ciobanu, Dana Mihaela, et al.
Publicado: (2019)

Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes
por: Bansal, Savita, et al.
Publicado: (2023)

Chronic Vascular Complications in Diabetes
por: Jia, Weiping, et al.
Publicado: (2013)

Vascular Effects of Dietary Advanced Glycation End Products
por: Stirban, Alin, et al.
Publicado: (2015)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
por: Mao, Lin, et al.
Publicado: (2022)

Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives
por: Liu, Jing, et al.
Publicado: (2023)

Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes
por: Sharma, Arpeeta, et al.
Publicado: (2012)

Association of diabetic vascular complications with poor sleep complaints
por: Meng, Ling-Ling, et al.
Publicado: (2016)

Genes associated with Type 2 Diabetes and vascular complications
por: Montesanto, Alberto, et al.
Publicado: (2018)

Mortality in adults with and without diabetes: is the gap widening?
por: Wang, Zhiqiang, et al.
Publicado: (2017)

The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
por: Kim, Wonjin, et al.
Publicado: (2014)

Fluorescent advanced glycation end products in type 2 diabetes and its association with diabetes duration, hemoglobin A1c, and diabetic complications
por: Liu, Rui, et al.
Publicado: (2022)

Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
por: Khullar, Madhu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_12b5ff5dtv7ts0vn9keejmq7mg